Medical Analysis

Understanding Lactate Dehydrogenase (LDH) Enzyme Function and Biological Significance

Lactate dehydrogenase (LDH) acts as a critical enzyme within the anaerobic metabolic pathway and is categorized as an oxidoreductase [4, 6]. Its primary biochemical role involves catalyzing the reversible conversion of pyruvate to lactate, a process that simultaneously facilitates the reduction of NAD+ to NADH and vice versa [6]. This reaction serves as a vital step in cellular energy generation, particularly under conditions of anaerobic respiration [4, 6]. LDH is ubiquitously distributed throughout the body, with significant concentrations located in the muscles, liver, kidneys, and red blood cells [4, 6]. When tissues containing this enzyme sustain injury or undergo disease-related damage, they release LDH into the bloodstream or other localized body fluids, making it a valuable, albeit non-specific, diagnostic marker [1, 6]. Historically, a “flipped pattern”—where LDH-1 levels exceed LDH-2 levels in serum—was utilized to suggest myocardial infarction; however, this diagnostic approach has been largely superseded by more specific tests such as Troponin I or T measurement [2, 5].

Comprehensive Guide for Non-Medicos: What is an LDH Test?

For individuals looking to understand the LDH test, it is essentially a way to check for tissue damage in the body [6]. Because this enzyme is found in almost all cells, when parts of your body (like your heart, liver, or muscles) are hurt or diseased, they leak LDH into your blood [6]. Doctors use this test as a general warning sign to see if there is cell damage happening somewhere [6]. While it cannot point to one specific disease on its own, it is very helpful for monitoring how well a treatment, such as chemotherapy, is working [8, 10]. Higher levels generally mean more tissue damage, while levels that go down during treatment often signal that the patient is recovering [8, 10].

Advanced Pathophysiology and Clinical Diagnostic Utility

LDH plays a foundational role in anaerobic metabolism by mediating the conversion between lactate and pyruvate via NAD utilization [4, 6]. Clinical significance arises because LDH is released into the bloodstream following cellular injury, such as liver trauma, or tissue damage like myocardial infarction [1, 2]. It is associated with various conditions including liver injury, haemolysis, malignancy, and muscle injury [6]. As a diagnostic marker, its concentration is directly proportional to the nature and severity of the injury, making it useful for monitoring disease progress and response to treatment [6, 8]. From a prognostic standpoint, persistent elevation of LDH often indicates a guarded prognosis, suggesting deterioration of disease status, increased tumor burden, or a failure to respond to therapeutic interventions [8, 10, 11].

Categorization of LDH Isoenzymes by Tissue Distribution

LDH exists in various isoenzyme forms, each with a distinct tissue presence [5, 7]:

Clinical Indications and Biomarker Applications

LDH testing is utilized across several clinical domains to assess tissue health and disease status [6].

• Tissue damage: Detects damage in tissues like heart, liver, muscles, kidneys, lungs [6].

• Myocardial infarction: Elevated LDH suggests heart attack [1, 2].

• Liver disease: Monitors liver conditions like hepatitis [6].

• Anemia: Helps diagnose types of anemia including hemolytic anemia [6].

• Infections: Detects severe infections impacting tissues [6, 12].

• Certain cancers: Lymphoma, leukemia, melanoma, testicular cancer [8, 13].

• Monitoring cancer treatment: Checks effectiveness of chemotherapy and treatment response [8, 10].

• Muscle diseases: Diagnoses muscular dystrophy [6].

• Fluid analysis: Evaluates pleural or pericardial fluids for inflammation [3, 14].

Furthermore, LDH serves as a significant biomarker in tumor diagnosis, particularly for conditions such as malignant lymphoma, invasive B-cell lymphoma, mantle cell lymphoma, follicular lymphoma, Wilms tumor, germ cell tumors, melanoma, gastric cancer, and renal cell carcinoma [8, 13].

Oncology-Specific Applications and Serum LDH Monitoring

In the field of oncology, LDH levels are frequently used as a non-specific tumor marker [8]. While elevated LDH does not identify a specific type of cancer, measuring these levels is highly effective for monitoring the efficacy of cancer treatment [8, 10]. Because tumor growth often results in significant tissue destruction, serum LDH levels provide crucial insights into the extent of tissue damage caused by malignant processes [8, 13].

Laboratory Methodologies and Sample Processing Requirements

The detection of LDH involves several standardized laboratory assays, including Immunoassay, Spectrophotometric Assay, Colorimetric Assay, and ELISA [15]. Proper sample collection is paramount for accurate results [6]. Clinicians must collect 3.0 mL of blood in a plain tube (red-capped) and separate the serum as early as possible [6]. Importantly, any haemolysed sample is considered unsuitable for assay, as the release of LDH from red blood cells during haemolysis will produce falsely elevated results [6].

Normal Reference Ranges and Clinical Interpretation

While the typical normal range for serum LDH is between 140 to 280 U/L, clinical interpretation must always be contextualized by the patient’s signs and symptoms [6]. Serum LDH levels are usually higher than plasma LDH levels because of the enzyme’s release during the clotting process [6].

Reference Ranges by Age Group

Normal Reference Ranges in Body Fluids

Note: Ascitic Fluid (F/S A): Fluid / Serum LDH ratio < 0.6 = Transudate; > 0.6 = Exudate [3].

Analysis of Body Fluids and Diagnostic Significance

The differentiation between exudates and transudates is guided by Light’s Criteria [3]. A ratio of pleural LDH to serum LDH greater than 0.6, or a value greater than two-thirds the upper limit of the normal laboratory value for serum LDH, indicates an exudate, while a lower ratio indicates a transudate [3]. In cases of empyema, LDH levels may exceed 1000 IU/L [3, 14]. Additionally, in the central nervous system, high levels of LDH in cerebrospinal fluid are often associated with bacterial meningitis [14]. In viral meningitis, high LDH typically indicates the presence of encephalitis, which is associated with a grave prognosis [14].

Etiology of Elevated LDH Levels: A Systematic Review

Elevated LDH levels are a hallmark of various systemic conditions, spanning multiple medical disciplines [6].

• Cardiorespiratory, Hematological, and Hepatic: Myocardial infarction, heart failure, pulmonary infection, hemolysis, leukemia, lymphoma, hepatitis, liver cirrhosis [1, 6, 8].

• Musculoskeletal and Nervous System: Muscle injury, muscular dystrophy, stroke, brain injury, meningitis, encephalitis [6, 14].

• Infectious, Malignant, and Miscellaneous: Sepsis, infectious mononucleosis, various cancers, renal failure, pancreatitis, hypothyroidism [6, 8, 12].

Genetic Basis and Molecular Mutations of LDH

The LDH enzyme is composed of M and H subunits encoded by distinct genes [9]. The M subunit is encoded by the LDHA gene, while the H subunit is encoded by the LDHB gene [9]. Mutations in these genes can lead to specific metabolic disorders, such as Lactate dehydrogenase-A deficiency (Glycogen Storage Disease XI) and Lactate dehydrogenase-B deficiency [9]. These conditions affect the body’s ability to break down sugars, primarily within specific muscle cells, and are inherited in an autosomal recessive pattern [9].

Critical Limitations of the LDH Test

It is essential to recognize the inherent limitations of LDH testing: lack of specificity and sensitivity, non-discriminatory nature, significant physiological fluctuation (diurnal, exertion, diet), and limited prognostic reliability [6, 15].

Prognostic Significance and Future Directions in Targeted Therapy

LDH levels are a simple, economical method for identifying a patient’s response to cancer treatments [8]. A decline in LDH indicates clinical improvement; persistent elevation suggests therapeutic failure [8]. Furthermore, high LDH is a documented cause of primary resistance to anti-PD(L)1 immunotherapy, as it contributes to tumor immune tolerance [11]. Emerging research suggests that LDH-targeted therapies could potentially improve the efficacy of checkpoint blockade immunotherapies [10, 11].

References:

1. Wróblewski, F., & LaDue, J. S. (1955). Lactic dehydrogenase activity in blood. Proceedings of the Society for Experimental Biology and Medicine, 90(1), 210–213.

2. Coodley, E. L. (1970). Diagnostic Enzymes in the Heart. Journal of the American Medical Association, 214(5), 903–905.

3. Light, R. W. (1972). Pleural effusions: The diagnostic separation of transudates and exudates. Annals of Internal Medicine, 77(4), 507–513.

4. Wilkinson, J. H. (1976). The Principles and Practice of Diagnostic Enzymology. Edward Arnold.

5. Rotenberg, Z., & Graff, E. (1990). The clinical significance of serum lactate dehydrogenase (LDH) isoenzymes. Harefuah, 118(8), 472–475.

6. Bais, R., & Edwards, J. B. (1982). Lactate dehydrogenase. CRC Critical Reviews in Clinical Laboratory Sciences, 16(4), 291–331.

7. Van der Helm, H. J. (1961). A simplified method of demonstrating lactic dehydrogenase isoenzymes in serum. The Lancet, 278(7193), 108–109.

8. Neuss, M. N., et al. (2017). Oncology Practice Information: Clinical Significance of Lactate Dehydrogenase in Cancer Patients. Journal of Oncology Practice, 13(8), 532–540.

9. Krawiec, J. A., et al. (2015). Genetic aspects of Lactate Dehydrogenase (LDH) deficiency. Molecular Genetics and Metabolism, 114(2), 241–245.

10. Felsher, D. W. (2018). Cancer metabolism: LDH-A as a therapeutic target. Nature Reviews Cancer, 18(6), 345–358.

11. Aggarwal, S., et al. (2020). LDH and its role in immunotherapy resistance. Frontiers in Immunology, 11, 1563–1575.

12. Li, X., et al. (2021). Serum Lactate Dehydrogenase as a prognostic biomarker in patients with COVID-19. Clinica Chimica Acta, 512, 1–8.

13. Zhao, Z., et al. (2022). Comprehensive analysis of the role of LDH isoenzymes in tumor cell metabolism. Cancer Cell International, 22(1), 123–139.

14. Giammarioli, A., et al. (2023). Diagnostic utility of lactate dehydrogenase in body fluid analysis. Journal of Clinical Laboratory Analysis, 37(4), 24420.

15. Smith, J. D., & Taylor, P. (2024). Advances in automated immunoassay methods for enzyme quantification. Clinical Chemistry and Laboratory Medicine, 62(1), 45–58.

FAQ’s:

• What is LDH enzyme?
  LDH is an enzyme found in almost all body tissues that helps convert sugar into energy.

• Why is LDH tested?
  It serves as a general marker to help doctors detect tissue damage, infections, or monitor cancer treatment.

• What do high levels mean?
  Elevated LDH indicates tissue damage, though it does not specify which organ or condition is the cause.

• Is LDH a specific test?
  No, it lacks specificity and sensitivity, meaning it must always be interpreted alongside other clinical tests.

• How is the sample collected?
  Blood is collected in a plain red-capped tube, and serum must be separated quickly to avoid hemolysis.

• What are LDH isoenzymes?
  There are five LDH forms (isoenzymes) found in specific tissues like the heart, lungs, and liver.

• Does cancer raise LDH?
  Yes, rapid tumor growth and tissue destruction often cause significantly elevated serum LDH levels in cancer patients.

• How to interpret fluid results?
  Doctors use Light’s Criteria—comparing fluid and serum LDH ratios—to distinguish between transudates and dangerous exudates.

• Can diet affect results?
  Yes, factors such as strenuous exercise, diet, and certain medications can cause fluctuations in LDH test results.

• How is treatment response monitored?
  A declining LDH level during chemotherapy typically indicates that the patient is responding positively to the treatment.

Related Diagnostic Tests

• Aspartate Aminotransferase (AST)

• Complete Blood Count (CBC)

• Creatine Kinase (CK)